CINECA IRIS Institutional Research Information System

FORNAI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.322
EU - Europa 4.659
AS - Asia 1.397
AF - Africa 231
SA - Sud America 21
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.101
IT - Italia 2.041
SE - Svezia 825
CN - Cina 632
BG - Bulgaria 423
DE - Germania 363
GB - Regno Unito 242
VN - Vietnam 228
CA - Canada 208
AT - Austria 193
TR - Turchia 156
CI - Costa d'Avorio 150
UA - Ucraina 135
SG - Singapore 124
FI - Finlandia 108
HK - Hong Kong 92
RU - Federazione Russa 92
IN - India 78
FR - Francia 61
CH - Svizzera 47
SN - Senegal 47
PL - Polonia 44
BE - Belgio 40
IR - Iran 25
NG - Nigeria 22
JP - Giappone 13
KR - Corea 12
MX - Messico 12
PK - Pakistan 11
NL - Olanda 10
BR - Brasile 9
AU - Australia 8
ES - Italia 7
CL - Cile 5
EC - Ecuador 5
IE - Irlanda 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
ID - Indonesia 4
UZ - Uzbekistan 4
EU - Europa 3
GH - Ghana 3
HU - Ungheria 3
LB - Libano 3
PH - Filippine 3
PT - Portogallo 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
MA - Marocco 2
RS - Serbia 2
UG - Uganda 2
BD - Bangladesh 1
BJ - Benin 1
BN - Brunei Darussalam 1
CM - Camerun 1
CO - Colombia 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
LV - Lettonia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PE - Perù 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 15.646
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.125
Fairfield 1.107
Ann Arbor 959
Houston 847
Chandler 828
Ashburn 566
Milan 470
Seattle 439
Wilmington 424
Sofia 423
Cambridge 387
Serra 382
Beijing 270
New York 251
Ottawa 194
Princeton 185
Jacksonville 161
Lawrence 161
Abidjan 150
Izmir 145
Vienna 142
Medford 140
Dong Ket 112
Nanjing 108
Pisa 108
Florence 104
Des Moines 103
Hong Kong 83
Rome 77
Bremen 76
Dearborn 62
London 55
Nanchang 54
Dakar 47
Lancaster 44
Falls Church 42
Bern 40
San Diego 40
Brussels 38
Redwood City 37
Frankfurt am Main 36
Pune 30
Jüchen 29
Los Angeles 29
Marseille 27
Hebei 26
Washington 26
Boulder 25
Warsaw 25
Lagos 22
Kunming 20
Norwalk 19
Tianjin 19
Boardman 17
Auburn Hills 16
Changsha 16
Ogden 16
Jiaxing 15
Livorno 15
Pistoia 15
Palermo 13
Shenyang 13
Detroit 12
Hefei 12
Lucca 12
Padova 12
Phoenix 12
Hangzhou 11
Nürnberg 11
Turin 11
Guangzhou 10
Bologna 9
Parma 9
Shanghai 9
Verona 9
Ancona 8
Omaha 8
Redmond 8
Singapore 8
Toronto 8
Aguascalientes 7
Council Bluffs 7
Fremont 7
Montecatini Terme 7
Tappahannock 7
Molise 6
Bergen 5
Cagliari 5
Columbus 5
Dallas 5
Düsseldorf 5
Indiana 5
Mumbai 5
Naples 5
Rho 5
Santiago 5
Tagliacozzo 5
Torino 5
Ballabio 4
Bari 4
Totale 11.743
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 354
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 182
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 177
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 173
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 165
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 159
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 145
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 145
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 145
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 140
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 138
Derivati benzofuranici come attivatori di AMPK 138
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 136
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 135
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 132
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 132
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 131
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 130
Preparation of isoindoline derivatives for use as AMPK activators 129
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 128
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 127
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 127
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 125
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 125
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 122
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 122
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 121
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 120
Adenosine and inflammation: what's new on the horizon? 120
Allopurinol adherence among patients with gout: an Italian general practice database study 120
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 119
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 119
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 118
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 118
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 117
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 116
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 116
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 116
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 115
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 115
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 115
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 114
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 114
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 114
Transient acute liver failure complicating transurethral resection syndrome 114
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 114
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 113
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 113
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 112
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 111
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 111
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 109
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 109
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 109
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 109
Role of A2a adenosine in the regulation of colonic motility in normal human colon 106
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 106
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 106
Adenosine pathway and cancer: where do we go from here? 106
Adenosine regulation of the immune system 106
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 104
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 103
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 103
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 103
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 103
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease 103
Quantitative and qualitative changes of colonic myenteric ganglia in patients with ulcerative colitis 102
NSAID activated gene (NAG-1) plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer repair 102
A holistic view of adenosine pathways in the control of intestinal neuromuscular functions: the enteric purinome concept 102
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis 101
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 101
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 101
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 101
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 100
Mechanisms underlying the non-anticoagulant effects of apixaban and dabigatran on the integrity of intestinal mucosa: a comparative pre-clinical study. 100
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 100
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 99
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 99
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 98
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 97
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 97
Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting 97
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 97
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 97
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? 97
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 96
Risankizumab for the treatment of moderate to severe psoriasis 93
Preparation of benzofuran derivatives for use as AMPK activators 93
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis 91
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders 91
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 91
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 91
Cycloxygenases 1 and 2 expression in neuromuscular compartment of normal human colon 90
Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a review 90
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 90
Effects of proton pump inhibitors on healing of gastric ulcerations induced by a continued non steroidal anti-inflammatory drug (NSAID) treatment 89
Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics? 89
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 89
Effects of selective and non-selective cyclooxygenase-2 inhibitors on mechanisms of gastric mucosal protection 88
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 88
Totale 11.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.203
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019946 0 0 0 0 0 0 0 0 0 306 357 283
2019/20203.000 333 224 198 202 284 301 316 264 325 195 286 72
2020/20211.643 136 106 120 82 123 80 70 124 216 189 86 311
2021/20222.001 36 97 62 114 377 282 79 118 109 84 138 505
2022/20232.936 321 388 210 291 299 371 34 239 507 49 195 32
2023/20242.114 245 254 302 198 385 408 64 111 104 43 0 0
Totale 16.307